Skip to report
Next edition in 508 min Oct 12, 23:00 - Oct 13, 09:00 Lisbon
Premarket Alpha Midday Alpha Post-Market Alpha

Daily Alpha · Reddit

Reddit split on memory after China's memory news, while other pitches included Raytheon's Coyote interceptor, WOLF and CLF on industrial policy, and a Biofrontera micro-cap thesis.

376threads

Themes on this desk

Memory after CXMT

One r/wallstreetbets author argues Chinese memory production removes memory stocks' scarcity premium; another calls the memory and Korean selloff an overreaction because Chinese progress will take years to hit the market.

Korea dip-buying

A r/wallstreetbets commenter went all-in on the 3x Korea ETF KORU as a swing trade, arguing the after-hours 12% drop is overblown.

Highest engagement

by score · day change
12score
r/AMD_Stock

AMD's Helios rack is on track and live with Meta, OpenAI, Anthropic and Microsoft, per an r/AMD_Stock post

The author reports from Lisa Su's OCP keynote that AMD's Helios rack-scale platform is fully on track and live with Meta, OpenAI, Anthropic and Microsoft, and urges buying the dip.

Helios doing quite well. At OCP during Lisa her keynote and it is fully on track and now live across

The author reads Helios progress as a reason to buy AMD's dip.

Watch Helios deployments at Meta, OpenAI, Anthropic and Microsoft.

Source →
0 comments
2score
r/wallstreetbets

Take-Two bull expects the next 1000% gain to come faster than the run since GTA 5

The commenter says TTWO is up roughly 1000% since GTA 5 came out and expects the next 1000% to come faster.

Since gta5 came out TTWO has been up 1000% percent.

The commenter points to TTWO's roughly 1000% gain since GTA 5 came out.

Source →
0 comments
2score
r/wallstreetbets

UiPath pitched as an AI governance beneficiary set to re-rate within two quarters

The author argues UiPath will be one of the biggest AI beneficiaries as it moves customers from pilot to production.

I will die on this hill but $PATH is going to be one of biggest beneficiaries of AI.

The author expects PATH to re-rate within two quarters.

Watch UiPath customers moving from pilot to production.

Source →
0 comments
1score
r/stocks

Raytheon unveiled a rocket-powered Coyote Block 2C+RM counter-drone interceptor

The post details Raytheon's new rocket-powered Coyote interceptor and frames RTX as the seller of the rounds.

Raytheon showed a rocket-powered version of its Coyote counter-drone interceptor Raytheon unveiled the Coyote Block 2C+RM.

The author treats RTX as the supplier of counter-drone rounds.

Watch Army orders for the Coyote interceptor.

Source →
0 comments
1score
r/wallstreetbets

Author adds to WOLF and CLF on a shift from government loans to defense offtake

The author argues WOLF and CLF will re-rate as US strategic industrial policy moves from government loans and contracts to defense offtake, and discloses increased core positions in both.

Connecting the dots pt 2: I told you the admin would write checks to CLF and WOLF.

The author ties both names to the administration's move from loans and contracts toward offtake agreements.

Watch Defense offtake arrangements for WOLF and CLF.

Source →
0 comments

Most argued

by comments per upvote
1score
r/IndianStockMarket

Brent above $105 called the key bearish driver for India's Nifty

The author argues Brent crude above $105 is the only macro chart that matters for Nifty right now, rather than technical lines.

The only macro chart that matters for Nifty right now (Forget the technical lines) Everyone on my feed is drawing

The author treats oil, not chart levels, as the driver for Indian equities.

Watch Brent relative to $105.

Source →
1 comment
1score
r/biotechplays

Bull case on Biofrontera after Ameluz's superficial BCC approval at a $14M valuation

The post cites Ameluz's FDA approval for superficial BCC, 80% gross margins and a near-breakeven Q2, arguing a $14M market cap misprices a commercial-stage company.

BFRI ($0.97): Ameluz sBCC approval + near-breakeven Q2 at a $14M valuation **Thesis:** Approved PDT product, growing revenue, 80% margins,

The author sees an approved, revenue-generating product priced at a $14M market cap.

Watch Ameluz sales after the superficial BCC approval.

Source →
0 comments
1score
r/wallstreetbets

Rocket Companies pitched as a long-term buy on a housing rebound

The author argues a housing rebound plus Rocket's scale, tech platform and acquisitions should drive earnings growth, citing $229M of Q2 2026 net income and market share gains.

could be a great long-term buy at these levels because the housing market won’t stay slow forever, and when it

The thesis is a bet that the housing market won't stay slow forever.

Watch A housing market rebound.

Source →
0 comments
1score
r/wallstreetbets

Long ITA on munitions depletion

The author is long the iShares U.S. Aerospace & Defense ETF, arguing the basket has to run as everyone uses up missiles and drones.

In long ITA - think this basket has to run back as everyone is using their missiles and drones up.

The thesis rests on defense demand rising as munitions are depleted.

Watch Munitions replenishment demand.

Source →
0 comments